Cargando…
Hemofiltration with the Seraph(®) 100 Microbind(®) Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients
Autores principales: | Kielstein, Jan T., Borchina, Dan-Nicolae, Fühner, Thomas, Hwang, Soyoon, Mattoon, Dawn, Ball, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169409/ https://www.ncbi.nlm.nih.gov/pubmed/34074339 http://dx.doi.org/10.1186/s13054-021-03597-3 |
Ejemplares similares
-
Treatment of a Critically Ill COVID-19 Patient with the Seraph 100 Microbind Affinity Filter
por: Pape, Anke, et al.
Publicado: (2021) -
Interim analysis of the COSA (COVID-19 patients treated with the Seraph(®) 100 Microbind(®) Affinity filter) registry
por: Schmidt, Julius J, et al.
Publicado: (2021) -
In vitro elimination of anti-infective drugs by the Seraph(®) 100 Microbind(®) affinity blood filter
por: Schmidt, Julius J, et al.
Publicado: (2020) -
Staphylococcus aureus binding to Seraph(®) 100 Microbind(®) Affinity Filter: Effects of surface protein expression and treatment duration
por: Seffer, Malin-Theres, et al.
Publicado: (2023) -
First-Time Use of the Seraph(®) 100 Microbind(®) Affinity Blood Filter in an Adolescent Patient with Severe COVID-19 Disease: A Case Report
por: Merrill, Kyle A., et al.
Publicado: (2023)